🇺🇸 FDA
Company

Revolution

Revolution Medicines

RVMD biotech USA

Quick answer

Revolution is a biotech company (RVMD) headquartered in REDWOOD CITY, CA, USA with 17 tracked pipeline programs.

Pipeline (17)

project

RMC-6236

Pancreatic Cancer

Phase 3 · small_molecule · active

1 trials project

daraxonrasib

NSCLC (Non-small Cell Lung Cancer)

Phase 3 · small_molecule · active

1 trials project

daraxonrasib

Pancreatic Cancer

Phase 3 · small_molecule · active

2 trials project

Daraxonrasib

Advanced Solid Tumors

Phase 2 · small_molecule · active

1 trials project

Elironrasib

Non-Small Cell Lung Cancer (NSCLC)

Phase 2 · small_molecule · active

1 trials project

RMC-4630

Solid Tumor

Phase 2 · small_molecule · completed

1 trials project

RMC-4630

Non-Small Cell Lung Cancer

Phase 2 · small_molecule · completed

1 trials project

RMC-6236

Colorectal Cancer

Phase 2 · small_molecule · active

1 trials project

RMC-6236

Non-small Cell Lung Cancer (NSCLC)

Phase 2 · small_molecule · active

1 trials project

RMC-6291

Non-Small Cell Lung Cancer, NSCLC

Phase 2 · small_molecule · active

2 trials project

TNG462

PDAC

Phase 2 · small_molecule · active

1 trials project

Vociprotafib

Metastatic Neoplasm

Phase 2 · small_molecule · terminated

1 trials project

RMC-4630

Solid Tumors

Phase 1 · small_molecule · active

1 trials project

RMC-5127

Non-small Cell Lung Cancer (NSCLC)

Phase 1 · small_molecule · active

1 trials project

RMC-5552

Solid Tumors

Phase 1 · small_molecule · completed

1 trials project

RMC-5552

Glioblastoma

Phase 1 · small_molecule · terminated

1 trials project

RMC-9805

Non-small Cell Lung Cancer (NSCLC)

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12409225

Ras inhibitors

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12403196

Ras inhibitors

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12384750

Ras inhibitors

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12365688

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12280113

Ras inhibitors

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12258366

Bicyclic heteroaryl compounds and uses thereof

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12252497

Ras inhibitors

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12202845

Ras inhibitors

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)